Literature DB >> 10074139

RNA-Stimulated ATPase and RNA helicase activities and RNA binding domain of hepatitis G virus nonstructural protein 3.

Y Gwack1, H Yoo, I Song, J Choe, J H Han.   

Abstract

Hepatitis G virus (HGV) nonstructural protein 3 (NS3) contains amino acid sequence motifs typical of ATPase and RNA helicase proteins. In order to examine the RNA helicase activity of the HGV NS3 protein, the NS3 region (amino acids 904 to 1580) was fused with maltose-binding protein (MBP), and the fusion protein was expressed in Escherichia coli and purified with amylose resin and anion-exchange chromatography. The purified MBP-HGV/NS3 protein possessed RNA-stimulated ATPase and RNA helicase activities. Characterization of the ATPase and RNA helicase activities of MBP-HGV/NS3 showed that the optimal reaction conditions were similar to those of other Flaviviridae viral NS3 proteins. However, the kinetic analysis of NTPase activity showed that the MBP-HGV/NS3 protein had several unique properties compared to the other Flaviviridae NS3 proteins. The HGV NS3 helicase unwinds RNA-RNA duplexes in a 3'-to-5' direction and can unwind RNA-DNA heteroduplexes and DNA-DNA duplexes as well. In a gel retardation assay, the MBP-HGV/NS3 helicase bound to RNA, RNA/DNA, and DNA duplexes with 5' and 3' overhangs but not to blunt-ended RNA duplexes. We also found that the conserved motif VI was important for RNA binding. Further deletion mapping showed that the RNA binding domain was located between residues 1383 and 1395, QRRGRTGRGRSGR. Our data showed that the MBP-HCV/NS3 protein also contains the RNA binding domain in the similar domain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074139      PMCID: PMC104049     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  The RNA helicase CI from plum pox potyvirus has two regions involved in binding to RNA.

Authors:  A Fernández; J A García
Journal:  FEBS Lett       Date:  1996-06-17       Impact factor: 4.124

2.  RNA helicase activity of the plum pox potyvirus CI protein expressed in Escherichia coli. Mapping of an RNA binding domain.

Authors:  A Fernández; S Laín; J A García
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

3.  Structure of the hepatitis C virus RNA helicase domain.

Authors:  N Yao; T Hesson; M Cable; Z Hong; A D Kwong; H V Le; P C Weber
Journal:  Nat Struct Biol       Date:  1997-06

4.  Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase.

Authors:  L Jin; D L Peterson
Journal:  Arch Biochem Biophys       Date:  1995-10-20       Impact factor: 4.013

5.  Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein.

Authors:  Y Gwack; D W Kim; J H Han; J Choe
Journal:  Biochem Biophys Res Commun       Date:  1996-08-14       Impact factor: 3.575

6.  The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3).

Authors:  C L Tai; W K Chi; D S Chen; L H Hwang
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Vaccinia virion protein I8R has both DNA and RNA helicase activities: implications for vaccinia virus transcription.

Authors:  C D Bayliss; G L Smith
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

9.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

10.  Molecular and serologic analysis in the transmission of the GB hepatitis agents.

Authors:  G G Schaluder; G J Dawson; J N Simons; T J Pilot-Matias; R A Gutierrez; C A Heynen; M F Knigge; G S Kurpiewski; S L Buijk; T P Leary
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more
  8 in total

1.  ATP hydrolysis and AMP kinase activities of nonstructural protein 2C of human parechovirus 1.

Authors:  Olga Samuilova; Camilla Krogerus; Igor Fabrichniy; Timo Hyypiä
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 2.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 3.  Helicases as antiviral drug targets.

Authors:  David N Frick
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

4.  An ATPase activity associated with the rotavirus phosphoprotein NSP5.

Authors:  Tamara Bar-Magen; Eugenio Spencer; John T Patton
Journal:  Virology       Date:  2007-09-06       Impact factor: 3.616

5.  Choosing between DNA and RNA: the polymer specificity of RNA helicase NPH-II.

Authors:  Jane Kawaoka; Anna Marie Pyle
Journal:  Nucleic Acids Res       Date:  2005-01-28       Impact factor: 16.971

Review 6.  Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Authors:  Mehdi Samadi; Vahid Salimi; Mohammad Reza Haghshenas; Seyed Mohammad Miri; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Virol J       Date:  2022-03-09       Impact factor: 4.099

7.  HrpA, an RNA helicase involved in RNA processing, is required for mouse infectivity and tick transmission of the Lyme disease spirochete.

Authors:  Aydan Salman-Dilgimen; Pierre-Olivier Hardy; Justin D Radolf; Melissa J Caimano; George Chaconas
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

8.  Functional properties of the predicted helicase of porcine reproductive and respiratory syndrome virus.

Authors:  Elida M Bautista; Kay S Faaberg; Dan Mickelson; Edward D McGruder
Journal:  Virology       Date:  2002-07-05       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.